Kouchakji Elias 4
4 · FIBROGEN INC · Filed Nov 19, 2020
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Kouchakji Elias
SVP, Clinical Dev, Drug Safety
Transactions
- Exercise/Conversion
Common Stock
2020-11-17$14.57/sh+7,082$103,220→ 134,495 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-11-17−7,082→ 0 totalExercise: $14.57Exp: 2024-03-19→ Common Stock (7,082 underlying)
Footnotes (1)
- [F1]Fully vested.